TABLE 3.

Risk factors for early relapse in pancreatic ductal adenocarcinoma (PDAC) patients who underwent neoadjuvant chemoradiotherapy

Variables		Univariate		Multivariate
		MRFS (months)	P value	OR (95% CI)	P‐value
CD3+ CD4+ T cell (cancer cell nest)	<9.0	13.5	.360
	>9.0	18.7
CD3+ CD8+ T cell (cancer cell nest)	<16.4	15.2	.622
	>16.4	12.9
CD20+ B cell (cancer cell nest)	<0.0	15.2	.747
	>0.0	6.6
CD3+ Foxp3+ T cell (cancer cell nest)	<0.5	13.5	.667
	>0.5	18.7
CD204+ cell (cancer cell nest)	<16.7	25.0	.032	2.366 (1.074‐5.215)	.033
	>16.7	6.9
PD‐L1 high carcinoma (cancer cell nest)	<0.0	22.5	.091	2.001 (0.912‐4.390)	.084
	>0.0	6.9

Abbreviations: CI, confidence interval; MRFS, median relapse free survival time; OR, Odds ratio.